Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. dr. Fritz Offner

Work address: C. Heymanslaan 10, ingang 12 - verdieping 6
9000 Gent
Email: Fritz.Offner@UGent.be
ORCID iD: 0000-0003-4690-3603

Show Sort by

Add to list
- Journal Article
- open access
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial

Nathan Hale Fowler, Michael Dickinson, Martin Dreyling, Joaquin Martinez-Lopez, Arne Kolstad, Jason Butler, Monalisa Ghosh, Leslie Popplewell, Julio C. Chavez, Emmanuel Bachy, et al.

(2022) NATURE MEDICINE. 28(2). p.325-+
Add to list
- Journal Article
- open access
The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study

Josee M. Zijlstra, George Follows, Rene-Olivier Casasnovas, Joost S. P. Vermaat, Nagesh Kalakonda, Sylvain Choquet, Brian Hill, Catherine Thieblemont, Federica Cavallo, Fatima De la Cruz, et al.

(2022) CANCERS. 14(3).
Add to list
- Journal Article
- open access
Nucleic Acid Biomarkers in Waldenstrom Macroglobulinemia and IgM-MGUS: Current Insights and Clinical Relevance

Daniela Drandi, Philippe Decruyenaere (UGent) , Martina Ferrante, Fritz Offner (UGent) , Jo Vandesompele (UGent) and Simone Ferrero

(2022) DIAGNOSTICS. 12(4).
Add to list
A unique phenotype of longitudinal extensive transverse myelitis in autoimmune lymphoproliferative syndrome

Cathérine Dekeyser (UGent) , Leslie Naesens (UGent) , Fritz Offner (UGent) , Ciel De Vriendt (UGent) , Alexander Schauwvlieghe (UGent) , Tessa Kerre (UGent) and Guy Laureys (UGent)

(2022) JOURNAL OF NEUROIMMUNOLOGY. 367.
Add to list
- Journal Article
- A1
- open access
Real-world estimation of first- and second-line treatments for diffuse large B-cell lymphoma using health insurance data : a Belgian population-based study

Willem Daneels (UGent) , Michael Rosskamp, Gilles Macq, Estabraq Ismael Saadoon, Anke De Geyndt, Fritz Offner (UGent) and Hélène A. Poirel

(2022) FRONTIERS IN ONCOLOGY. 12.
Add to list
Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myeloma

Arthur Bobin, Maeva Kyheng, Stephanie Guidez, Cecile Gruchet-Merouze, Valentine Richez, Alain Duhamel, Lionel Karlin, Brigitte Kolb, Mourad Tiab, Carla Araujo, et al.

(2022) LEUKEMIA. 36(3). p.881-884
Add to list
Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma

Nicolas Leupin, Pier Luigi Zinzani, Franck Morschhauser, Stephane Dalle, Marie Maerevoet, Jean-Marie Michot, Vincent Ribrag, Fritz Offner (UGent) , Marie Beylot-Barry, Helene Moins-Teisserenc, et al.

(2022) CANCER. 128(5). p.1004-1014
Add to list
Comparison of the effectiveness and safety of the oral selective inhibitor of nuclear export, selinexor, in diffuse large B cell lymphoma subtypes

Rene-Olivier Casasnovas, George Follows, Josee M. Zijlstra, Joost S. P. Vermaat, Nagesh Kalakonda, Sylvain Choquet, Eric Van den Neste, Brian Hill, Catherine Thieblemont, Federica Cavallo, et al.

(2022) CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 22(1). p.24-33
Add to list
- Journal Article
- A1
- open access
Prolonged remissions after nivolumab plus gemcitabine/oxaliplatin in relapsed/refractory T-cell lymphoma

Roch Houot, Viola Poeschel, Bettina Altmann, Stephanie Angel, Lorenz Thurner, Thomas Illmer, Marc Andre, Martin Dreyling, Herve Maisonneuve, Herve Tilly, et al.

(2022) HEMASPHERE. 6(2).
Add to list
Identifying patients with chronic lymphocytic leukemia without need of treatment : end of endless watch and wait?

Christian Brieghel, Veerle Galle (UGent) , Rudi Agius, Caspar Da Cunha-Bang, Michael A. Andersen, Philip Vlummens (UGent) , Mattias Mattsson, Richard Rosenquist, Karin E. Smedby, Carmen D. Herling, et al.

(2022) EUROPEAN JOURNAL OF HAEMATOLOGY. 108(5). p.369-378

1
2
3
4
…
30
31

Next →